173 related articles for article (PubMed ID: 20694291)
1. [Pro-hepcidin, its relation with indicators of iron metabolism and of inflammation in patients hemodialyzed treated or not with recombinant erythropoietin].
Barrios Y; Espinoza M; Barón MA
Nutr Hosp; 2010; 25(4):555-60. PubMed ID: 20694291
[TBL] [Abstract][Full Text] [Related]
2. Does hepcidin affect erythropoiesis in hemodialysis patients?
Eleftheriadis T; Kartsios C; Liakopoulos V; Antoniadi G; Ditsa M; Papadopoulos C; Anifandis G; Skirta A; Markala D; Stefanidis I
Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323
[TBL] [Abstract][Full Text] [Related]
3. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
4. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
[TBL] [Abstract][Full Text] [Related]
5. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
[TBL] [Abstract][Full Text] [Related]
6. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
[TBL] [Abstract][Full Text] [Related]
7. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
Malyszko J; Malyszko JS; Mysliwiec M
Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
[TBL] [Abstract][Full Text] [Related]
8. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
[TBL] [Abstract][Full Text] [Related]
9. Plasma prohepcidin positively correlates with hematocrit in chronic hemodialysis patients.
Hsu SP; Chiang CK; Chien CT; Hung KY
Blood Purif; 2006; 24(3):311-6. PubMed ID: 16479095
[TBL] [Abstract][Full Text] [Related]
10. Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients.
Arabul M; Gullulu M; Yilmaz Y; Eren MA; Baran B; Gul CB; Kocamaz G; Dilek K
Med Sci Monit; 2009 Nov; 15(11):CR583-7. PubMed ID: 19865058
[TBL] [Abstract][Full Text] [Related]
11. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M.
Beirão I; Almeida S; Swinkels D; Costa PM; Moreira L; Fonseca I; Freitas C; Cabrita A; Porto G
Blood Cells Mol Dis; 2008; 41(2):175-8. PubMed ID: 18544472
[TBL] [Abstract][Full Text] [Related]
12. Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C.
Caliskan Y; Yelken B; Ozkok A; Gorgulu N; Yazici H; Telci A; Yildiz A
BMC Nephrol; 2012 Jul; 13():56. PubMed ID: 22768976
[TBL] [Abstract][Full Text] [Related]
13. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
[TBL] [Abstract][Full Text] [Related]
14. [Serum prohepcidin and other iron metabolism parameters in healthy adults].
Zekanowska E; Boinska J; Kwapisz J; Kedziora-Kornatowska K; Porzych K; Ratajczak M
Przegl Lek; 2011; 68(2):82-6. PubMed ID: 21751515
[TBL] [Abstract][Full Text] [Related]
15. Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: potential role of prohepcidin, hepcidin, and inflammation.
Malyszko J; Malyszko JS; Mysliwiec M
Ren Fail; 2009; 31(7):544-8. PubMed ID: 19839848
[TBL] [Abstract][Full Text] [Related]
16. Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes.
Aso Y; Takebayashi K; Wakabayashi S; Momobayashi A; Sugawara N; Terasawa T; Naruse R; Hara K; Suetsugu M; Morita K; Inukai T
Diabetes Res Clin Pract; 2010 Dec; 90(3):250-5. PubMed ID: 20888657
[TBL] [Abstract][Full Text] [Related]
17. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients.
Hackeng CM; Beerenhout CM; Hermans M; Van der Kuy PH; Van der Dussen H; Van Dieijen-Visser MP; Hamulyák K; Van der Sande FM; Leunissen KM; Kooman JP
J Nephrol; 2004; 17(1):107-11. PubMed ID: 15151266
[TBL] [Abstract][Full Text] [Related]
18. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks.
Schuemann K; Solomons NW; Laarakkers CM; Romero-Abal ME; Kroll S; Weiss G; Swinkels DW
Ann Nutr Metab; 2011; 58(2):158-66. PubMed ID: 21654163
[TBL] [Abstract][Full Text] [Related]
20. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
